The bank posted net income of $13 billion, down 7% from a year earlier due to a $2.2 billion pre-tax credit reserve build related to its pending acquisition of the Apple Card portfolio from Goldman Sachs. Revenue rose 7% to $46.8 billion, while net interest income climbed 7% to $25.1 billion, driven by higher revolving credit card balances and improved deposit margins.
“As the first bank to report results and the largest bank in the U.S., JPMorgan’s earnings serve as a barometer of consumer, corporate, and financial system health,” Morningstar Director Sean Dunlop wrote in a note on Tuesday. “The bank’s broad-based revenue growth suggests all three remain in good shape, though management’s tone and excess reserves point to a cautious outlook beyond 2026.” Dunlop raised his fair value estimate for JPM shares to $289 from $259, while still viewing the stock as expensive.
CFO Jeremy Barnum said on the earnings call that consumers and small businesses remain resilient. JPMorgan projected 2026 expenses of about $105 billion, with Barnum describing the increase as a function of structural optimism and the need to invest to stay ahead. “More generally, the environment is only getting more competitive, and so it remains critical to ensure that we are making the necessary investments to secure our position against both traditional and non-traditional competitors,” he explained.
During the Q&A session, CEO Jamie Dimon said higher spending, including on technology and AI, is necessary to compete with fintechs such as Revolut and SoFi, as well as established financial firms like Charles Schwab.
“These are good players,” Dimon said to analysts on the call. “We analyze what they do and how they do it… We are going to stay out front — so help us God. We’re not going to try to meet some expense target and then 10 years from now you’d be asking us the question, ‘How did JPMorgan get left behind?'”
Barnum also warned that President Donald Trump’s proposal to cap credit card interest rates at 10% would likely reduce access to credit rather than help consumers, arguing that intense competition already compresses margins and that price controls would force broad lending cutbacks — especially for higher-risk borrowers.
Sheryl Estrada
Betsabe Botaitis was appointed CFO of P2P.org, a non-custodial institutional staking provider. Botaitis brings over 20 years of leadership across financial services, fintech, and Web3, with experience building governance and operations in high-growth organizations. Most recently, Botaitis served as CFO and treasurer at Hedera. Botaitis’ career spans both traditional financial institutions and crypto-native organizations. She began in retail banking before holding senior finance roles at Citigroup and LendingClub, and later co-founding and serving as CFO of a blockchain company.
Julie Feder was appointed CFO of Obsidian Therapeutics, Inc., a clinical-stage biotechnology company. Feder brings over 20 years of strategic finance experience in life sciences and health care. Feder joins Obsidian from Aura Biosciences, where she served as CFO for six years. Before Aura, she was CFO at Verastem. Before that, Feder spent six years at the Clinton Health Access Initiative, Inc., as CFO.
